Novel modality share of oncology trials
RecordSTO-C1PEKQRJ2V-B7SA84ZXAH-P0ZQ03
Global · 2024
Novel modality share of oncology trials worldwide was 35% in 2024 (IQVIA).
Novel modality share of oncology trials: every country and year, and how it is measured
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Locator
- Key Findings: Oncology R&D activity continues to grow driven by novel modalities
- Retrieved
- 16 Sep 2026
- Status
- Verified
What the source says
Novel oncology modalities, especially cell and gene therapies, antibody-drug conjugates (ADCs), and multispecific antibodies, now account for 35% of oncology trials
Checked: the figure 35%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IQVIA Institute. (2024). Global Oncology Trends 2025. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Via StatOrigin, https://statorigin.org/stat/stat_C1PEKQRJ2VB7SA84ZXAHP0ZQ03
Other formats: MLA, Chicago, BibTeX
- MLA
- IQVIA Institute. "Global Oncology Trends 2025." 2024, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed 16 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_C1PEKQRJ2VB7SA84ZXAHP0ZQ03.
- Chicago
- IQVIA Institute. "Global Oncology Trends 2025." 2024. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_C1PEKQRJ2VB7SA84ZXAHP0ZQ03.
- BibTeX
- @misc{iqvia2024novelp0zq03, author = {{IQVIA Institute}}, title = {Global Oncology Trends 2025}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_C1PEKQRJ2VB7SA84ZXAHP0ZQ03}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Global Oncology Trends 2025
- Type
- Press release
- Published
- —
- Locator
- Key Findings: Oncology R&D activity continues to grow driven by novel modalities
- Retrieved
- 16 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_C1PEKQRJ2VB7SA84ZXAHP0ZQ03